We overlaid those USP7 peaks with non-canonical PRC1.1 peaks and canonical PRC1 peaks that we identified in our previous study in a cohort of six primary AML CD34+ patient samples (van den Boom et al., 2016). The gene discussed is PRC1; the disease is acute myeloid leukemia.